Imaging Recommendations for Diagnosis, Staging, and Management of Pediatric Solid Tumors

Abstract

Paediatric extra-cranial solid tumours are one of the common causes for paediatric malignancies. Lack of appropriate imaging at presentation, staging and for follow-up is a major challenge for paediatric solid tumours. We have reviewed the paediatric solid tumour imaging protocols suggested by the major oncological societies/groups around the world (mainly the SIOP – Society International Pediatric Oncology, and the COG – Children's Oncology Group). We have adapted some of those protocols to develop imaging recommendations for the diagnosis, staging and management of extra-cranial solid tumours based on the treatment protocols followed in India.

Keywords

hepatoblastoma - imaging guidelines - neuroblastoma - pediatric oncology - pediatric solid tumors - Wilm's tumor

Note

The article is not under consideration for publication elsewhere. Each author participated sufficiently for the work to be submitted. Publication is approved by all authors.

Publikationsverlauf

Artikel online veröffentlicht:
06. März 2023

• References

• 1 Bhakta N, Force LM, Allemani C. et al. Childhood cancer burden: a review of global estimates. Lancet Oncol 2019; 20 (01) e42-e53
• 2 Johnston WT, Erdmann F, Newton R, Steliarova-Foucher E, Schüz J, Roman E. Childhood cancer: Estimating regional and global incidence. Cancer Epidemiol 2021; 71 (Pt B): 101662
• 3 Kushner BH, Khakoo Y. Enigmatic entities: opsoclonus myoclonus ataxia syndrome linked to neuroblastoma. Lancet Child Adolesc Health 2018; 2 (01) 3-5
• 4 Maas MH, Cransberg K, van Grotel M, Pieters R, van den Heuvel-Eibrink MM. Renin-induced hypertension in Wilms tumor patients. Pediatr Blood Cancer 2007; 48 (05) 500-503
• 5 Yhoshu E, Lone YA, Mahajan JK, Singh UB. Hepatoblastoma with precocious puberty. J Indian Assoc Pediatr Surg 2019; 24 (01) 68-71
• 6 Schooler GR, Squires JH, Alazraki A. et al. Pediatric hepatoblastoma, hepatocellular carcinoma, and other hepatic neoplasms: Consensus Imaging Recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group. Radiology 2020; 296 (03) 493-497
• 7 Callahan MJ, Cravero JP. Should I irradiate with computed tomography or sedate for magnetic resonance imaging?. Pediatr Radiol 2022; 52 (02) 340-344
• 8 Ng K, Mogul DB. Pediatric liver tumors. Clin Liver Dis 2018; 22 (04) 753-772
• 9 Czauderna P, Lopez-Terrada D, Hiyama E, Häberle B, Malogolowkin MH, Meyers RL. Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 2014; 26 (01) 19-28
• 10 Spector LG, Birch J. The epidemiology of hepatoblastoma. Pediatr Blood Cancer 2012; 59 (05) 776-779
• 11 Towbin AJ, Meyers RL, Woodley H. et al. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol 2018; 48 (04) 536-554
• 12 Agarwala S, Gupta A, Bansal D. et al. Management of hepatoblastoma: ICMR consensus document. Indian J Pediatr 2017; 84 (06) 456-464
• 13 Cunningham ME, Klug TD, Nuchtern JG. et al. Global disparities in Wilms tumor. J Surg Res 2020; 247: 34-51
• 14 Charlton J, Irtan S, Bergeron C, Pritchard-Jones K. Bilateral Wilms tumour: a review of clinical and molecular features. Expert Rev Mol Med 2017; 19: e8
• 15 Nelson MV, van den Heuvel-Eibrink MM, Graf N, Dome JS. New approaches to risk stratification for Wilms tumor. Curr Opin Pediatr 2021; 33 (01) 40-48
• 16 Qureshi SS, Kembhavi SA, Bhagat M. et al. Customized approach for upfront or delayed resection using radiological criteria in unilateral, nonmetastatic pediatric renal tumors: a prospective study. Pediatr Blood Cancer 2019; 66 (Suppl. 03) e27815
• 17 Qureshi SS, Bhagat M, Kazi M. et al. Standardizing lymph nodal sampling for Wilms tumor: a feasibility study with outcomes. J Pediatr Surg 2020; 55 (12) 2668-2675
• 18 Qureshi SS, Bhagat M, Smriti V. et al. Intravascular extension of Wilms tumor: Characteristics of tumor thrombus and their impact on outcomes. J Pediatr Urol 2021; 17 (01) 69.e1-69.e8
• 19 NCG guidelines. 2020. Paediatric hematolymphoid and solid tumours. Accessed November 07, 2022, at: https://tmc.gov.in/ncg/index.php/107-guidlines
• 20 Kembhavi SA, Qureshi S, Vora T. et al. Understanding the principles in management of Wilms' tumour: can imaging assist in patient selection?. Clin Radiol 2013; 68 (07) 646-653
• 21 Prasad M, Vora T, Agarwala S. et al. Management of Wilms tumor: ICMR consensus document. Indian J Pediatr 2017; 84 (06) 437-445
• 22 Shaikh F, Murray MJ, Amatruda JF. et al. Paediatric extracranial germ-cell tumours. Lancet Oncol 2016; 17 (04) e149-e162
• 23 Faure-Conter C, Rocourt N, Sudour-Bonnange H. et al. [Pediatric germ cell tumours]. Bull Cancer 2013; 100 (04) 381-391
• 24 Horton Z, Schlatter M, Schultz S. Pediatric germ cell tumors. Surg Oncol 2007; 16 (03) 205-213
• 25 Agarwala S, Mitra A, Bansal D. et al. Management of pediatric malignant germ cell tumors: ICMR consensus document. Indian J Pediatr 2017; 84 (06) 465-472
• 26 Dieckmann KP, Frey U, Lock G. Contemporary diagnostic work-up of testicular germ cell tumours. Nat Rev Urol 2013; 10 (12) 703-712
• 27 Feldman DR. State-of-the-art management of germ cell tumors. Am Soc Clin Oncol Educ Book 2018; 38 (38) 319-323
• 28 Matthay KK, Shulkin B, Ladenstein R. et al. Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. Br J Cancer 2010; 102 (09) 1319-1326
• 29 Monclair T, Brodeur GM, Ambros PF. et al; INRG Task Force. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 2009; 27 (02) 298-303
• 30 Kembhavi SA, Shah S, Rangarajan V, Qureshi S, Popat P, Kurkure P. Imaging in neuroblastoma: An update. Indian J Radiol Imaging 2015; 25 (02) 129-136
• 31 Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. J Nucl Med 2009; 50 (08) 1237-1243
• 32 Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014; 64 (02) 83-103
• 33 Ripperger T, Bielack SS, Borkhardt A. et al. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A 2017; 173 (04) 1017-1037
• 34 Skapek SX, Ferrari A, Gupta AA. et al. Rhabdomyosarcoma. Nat Rev Dis Primers 2019; 5 (01) 1
• 35 Arndt CAS, Bisogno G, Koscielniak E. Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned. Cancer Treat Rev 2018; 68: 94-101
• 36 Hibbitts E, Chi YY, Hawkins DS. et al. Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: a report from the Children's Oncology Group. Cancer Med 2019; 8 (14) 6437-6448
• 37 van Ewijk R, Schoot RA, Sparber-Sauer M. et al; Cooperative Weichteilsarkom Studiengruppe Imaging Group, the European Society of Paediatric Radiology Oncology Task Force and the European Paediatric Soft Tissue Sarcoma Study Group Imaging Committee. European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology. Pediatr Radiol 2021; 51 (10) 1940-1951
• 38 O JH, Lodge MA, Wahl RL. O JH. Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0. Radiology 2016; 280 (02) 576-584
• 39 Accessed November 07, 2022, at: https://tmc.gov.in/tmh/pdf/EBM%202018-Guidelines%20for%20Paediatric%20Solid%20Tumours.pdf
• 40 Crist WM, Anderson JR, Meza JL. et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001; 19 (12) 3091-3102
• 41 Raney RB, Walterhouse DO, Meza JL. et al. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol 2011; 29 (10) 1312-1318
• 42 Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol 2009; 93 (09) 1129-1131
• 43 Rodriguez-Galindo C, Orbach DB, VanderVeen D. Retinoblastoma. Pediatr Clin North Am 2015; 62 (01) 201-223
• 44 Rangamani S, SathishKumar K, Manoharan N. et al. Paediatric retinoblastoma in India: evidence from the National Cancer Registry Programme. Asian Pac J Cancer Prev 2015; 16 (10) 4193-4198
• 45 Stathopoulos C, Lumbroso-Le Rouic L, Moll AC. et al. Current indications of secondary enucleation in retinoblastoma management: a position paper on behalf of the European Retinoblastoma Group (EURbG). Cancers (Basel) 2021; 13 (14) 3392